跳至主要内容
临床试验/CTRI/2024/05/068102
CTRI/2024/05/068102尚未招募不适用

To Study the Natural History and Prognosis of Patients with Acute- On-Chronic Liver Failure [ACLF): A Multicentric Prospective Study

NA1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年6月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
NA
入组人数
20
试验地点
1
主要终点
To study the acute and chronic insult which have impact on outcomes of ACLF

研究概览

简要总结

Upon receiving the consent from the patient, Following data is to be collected as follows:

Clinical history and examination

Mode of decompensation

Etiology of acute event

Etiology of chronic event

Severity assessment indices

Complications if any

Investigations

Hematology

CBC, Prothrombin time and INR, Peripheral smear, Reties Biochemistry

Liver function testing, AFP

Kidney function test

Etiology of acute event:

Infectious etiology: IgM anti HAY , lgM anti HEY, lgM anti HBc ( If HBsAg +ve), lgM anti HDY ( If HBsAg +ve), HEY RNA

Non Infectious etiology: Alcohol binging in last 4 weeks, hepatotoxic drugs, ANA (> 1: 80), lgG, surgeries in past 4 weeks. acute variceal bleed within 4 weeks

Etiology of underlying chronic liver disease :

Infectious etiology: total anti HBc, anti HCY, HCY RNA, HBY DNA

Non infectious etiology: Autoimmune markers, copper studies, iron studies.

HOMA IR, FBS

Ascitic fluid analysis

UGI endoscopy and liver biopsy as needed

Any other investigations as per clinical need and judgement of physician

Imaging

USG abdomen with Doppler for spleno-portal axis OR CECT- Triple phase upper abdomen

Follow-up

Treatment will be done as per treating physician

Physical examination will be done daily, after I week and at 4 weeks, at 2 months, at 3 months and at 6 months

CBC on alternate day for 1 week, at end of I week and then at end of 4 weeks at 2 months, at 3 months and at 6 months

KFT on alternate day for 1 week, at end of 1 week and then at end of 4 weeks, at 2 months, at 3 months and at 6 months

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • All patients with acute hepatic insult manifesting as jaundice (Sr. Bi l.
  • 5 mg/dL) and coagulopathy (INR 1.5), complicated within 4 weeks by ascites and/or encephalopathy in a patient with previously diagnosed or undiagnosed chronic liver disease.

排除标准

  • Age less than 18 and more than 75 years HCC or Extra-hepatic malignancy Pregnancy Patients being taken up for transplant Refusal to participate in the study.

结局指标

主要结局

To study the acute and chronic insult which have impact on outcomes of ACLF

时间窗: Day 0, Day 4, Day 7, Day 30, Day 180 and Day 365

次要结局

  • To study the acute and chronic insults which have an impact on outcome of ACLF(To study whether sepsis is a cause or effect of ACLF and define the Golden therapeutic window)

研究者

发起方
NA
申办方类型
Other [nil]
责任方
Principal Investigator
主要研究者

Dr Shiran Shetty

Manipal Academy of Higher Education

研究点 (1)

Loading locations...

相似试验

To check the natural history and prognosis in... | 临床试验